| Timothy Hall, CRNA | |
|
600 Mt Highway 91 S, Dillon, MT 59725-7379 | |
| (406) 683-3000 | |
| Not Available |
| Full Name | Timothy Hall |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 600 Mt Highway 91 S, Dillon, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902125628 | NPI | - | NPPES |
| 2036625 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | AP60469187 (Washington) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 0024168780 (Virginia) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Everett Clinic Pllc | 6406752153 | 552 |
News Archive
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease patients treated with Spiolto Respimat, which were presented today at the European Respiratory Society International Congress 2018 in Paris, France
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
MRIGlobal today announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
› Verified 6 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease patients treated with Spiolto Respimat, which were presented today at the European Respiratory Society International Congress 2018 in Paris, France
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
MRIGlobal today announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy Hall, CRNA Po Box 5127, Everett, WA 98206-5127 Ph: (425) 258-3900 | Timothy Hall, CRNA 600 Mt Highway 91 S, Dillon, MT 59725-7379 Ph: (406) 683-3000 |
News Archive
Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.
Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease patients treated with Spiolto Respimat, which were presented today at the European Respiratory Society International Congress 2018 in Paris, France
Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.
MRIGlobal today announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.
Researchers funded by the National Institutes of Health have developed a flexible brain implant that could one day be used to treat epileptic seizures. In animal studies, the researchers used the device - a type of electrode array that conforms to the brain's surface - to take an unprecedented look at the brain activity underlying seizures.
› Verified 6 days ago
Mr. Neal M Maxfield, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3000 | |
Dennis B. Hatfield, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 90 Highway 91 South, Dillon, MT 59725 Phone: 406-683-2323 | |
Kathleen S Maunu, RN, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3000 Fax: 406-683-3027 | |
Gordon H. Lucas, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 90 Highway 91 South, Dillon, MT 59725 Phone: 406-683-3000 | |
Kenny Joe Wallen, D.N.P. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 600 State Hwy 91 S, Dillon, MT 59725 Phone: 406-683-3000 | |
Mr. Cecil Timothy Jackson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 90 Highway 91 South, C/o Barrett Hospital & Healthcare, Dillon, MT 59725 Phone: 406-683-3000 Fax: 406-683-3011 |